Clinical Study of the Use of Amino Acid Peritoneal Dialysate in Diabetic Patients

Inclusion Criteria

• •Type I or II diabetes patients aged 18 to 75 years (including 18 and 75 years), regardless of gender;
• •Stable peritoneal dialysis patients who have undergone peritoneal dialysis treatment for ≥ 3 months;
• •Use 3-5 bags of peritoneal dialysis solution daily;
• •6.0%\<glycated hemoglobin (HbA1c) level ≤ 8.5%;
• •90g/L ≤ Hemoglobin concentration ≤ 130g/L
• •Stable use of erythropoietin and rosuvastatin;
• •The fluctuation of carbohydrate energy supply ratio in the first 3 months before enrollment is less than 15%;
• •Not using amino acid (15) peritoneal dialysis solution for the first 3 months before enrollment;
• •Within the past month, the patient's prescription for hypoglycemic drugs has not been adjusted;
• •Within the past month, the patient's dietary structure and food intake have remained stable.